Palatin Technologies
PTN
#10700
Rank
A$26.72 M
Marketcap
A$15.02
Share price
7.61%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -A$9.22 Million

According to Palatin Technologies's latest financial reports the company's current earnings are A$12.88 Million. In 2025 the company made an earning of -A$13.44 Million, an increase over its 2024 earnings that were of -A$37.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$9.22 Million-31.41%
2025 -A$13.44 Million-64.29%
2024 -A$37.64 Million-16.9%
2023 -A$45.29 Million5.99%
2022 -A$42.74 Million-13.7%
2021 -A$49.52 Million33.25%
2020 -A$37.16 Million-172.11%
2019 A$51.52 M2352.33%
2018 A$2.1 M-94.13%
2017 A$35.8 M-154.92%
2016 -A$65.2 Million3.67%
2015 -A$62.89 Million878%
2014 -A$6.43 Million-72.64%
2013 -A$23.51 Million-33.11%
2012 -A$35.14 Million77.71%
2011 -A$19.77 Million
2003 -A$33.48 Million29.93%
2002 -A$25.77 Million36.18%
2001 -A$18.92 Million
1999 -A$15.71 Million6.04%
1998 -A$14.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.29 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.48 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$1.11 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-A$16.37 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.26 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$0.16 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$41.2 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$80.96 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA